
"NIH Initiates Long COVID Trials for Autonomic Nervous System Dysfunction Treatments"
The National Institutes of Health (NIH) has initiated two phase 2 clinical trials as part of the RECOVER Initiative to evaluate treatments for autonomic nervous system dysfunction in adults with long COVID, focusing on symptoms such as fast heart rate, dizziness, and fatigue. The trials will test three potential treatments, including intravenous immunoglobulin, oral medication to reduce heart rate, and non-drug care. The initiative aims to address the debilitating symptoms of long COVID and is actively enrolling diverse participants across the United States.
